Retasturtide is a recently introduced novel GLP-1 receptor agonist demonstrating substantial results in the control of type 2 diabetes. This synthetic peptide duplicates the actions of naturally produced GLP-1, a hormone that plays a crucial role in managing blood glucose levels. By stimulating GLP-1 receptors in the pancreas, Retasturtide facilit